Abstract
In the presence of KF as base and THF as solvent, the tandem Michael addition-elimination reaction of different 5-alkoxy-3,4-dihalo-2(5H)-furanones with aminomethyl benzimidazoles at room temperature gave 21 target compounds simultaneously containing both bioactive benzimidazole and 2(5H)-furanone moieties in yields of 62-88 % (mostly over 71 %). The structures of all the newly synthesized compounds were elucidated and confirmed by FTIR, UV, 1H NMR, 13C NMR, mass spectroscopy and elemental analysis. The simple one-pot synthetic method provides a brief route for the introduction of the benzimidazole unit into 2(5H)-furanone derivatives under mild conditions without any metal catalysts. This transformation also affords an important synthetic strategy for the series 2(5H)-furanone derivatives, as well as a basis for the activity test of these potential drug molecules.
Keywords: Benzimidazole, bioactive units, combination, Csp2-N bond formation, 2(5H)-furanone, metal-free catalysis, Michael addition-elimination reaction, one-pot synthesis.
Letters in Organic Chemistry
Title:One-Pot Synthesis of 5-Alkoxy-4-amino-3-halo-2(5H)-furanones Containing Benzimidazole Moiety in the Absence of Metal Catalyst
Volume: 12 Issue: 5
Author(s): Pai Peng, Min-Hua Feng, Jie Shi, Jia-Li Zheng, Yan-Cheng Wu, Zhao-Yang Wang and Ren-Hong Chen
Affiliation:
Keywords: Benzimidazole, bioactive units, combination, Csp2-N bond formation, 2(5H)-furanone, metal-free catalysis, Michael addition-elimination reaction, one-pot synthesis.
Abstract: In the presence of KF as base and THF as solvent, the tandem Michael addition-elimination reaction of different 5-alkoxy-3,4-dihalo-2(5H)-furanones with aminomethyl benzimidazoles at room temperature gave 21 target compounds simultaneously containing both bioactive benzimidazole and 2(5H)-furanone moieties in yields of 62-88 % (mostly over 71 %). The structures of all the newly synthesized compounds were elucidated and confirmed by FTIR, UV, 1H NMR, 13C NMR, mass spectroscopy and elemental analysis. The simple one-pot synthetic method provides a brief route for the introduction of the benzimidazole unit into 2(5H)-furanone derivatives under mild conditions without any metal catalysts. This transformation also affords an important synthetic strategy for the series 2(5H)-furanone derivatives, as well as a basis for the activity test of these potential drug molecules.
Export Options
About this article
Cite this article as:
Peng Pai, Feng Min-Hua, Shi Jie, Zheng Jia-Li, Wu Yan-Cheng, Wang Zhao-Yang and Chen Ren-Hong, One-Pot Synthesis of 5-Alkoxy-4-amino-3-halo-2(5H)-furanones Containing Benzimidazole Moiety in the Absence of Metal Catalyst, Letters in Organic Chemistry 2015; 12 (5) . https://dx.doi.org/10.2174/1570178612666150305002655
DOI https://dx.doi.org/10.2174/1570178612666150305002655 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Role of Vitamin D in Atherosclerosis Inflammation Revisited: More a Bystander than a Player?
Current Vascular Pharmacology Non-Invasive Markers of Liver Fibrosis in HCV Mono-Infected and in HIV/HCV Co-Infected Subjects
Medicinal Chemistry Conditionally Replicating Adenoviruses for Cancer Treatment
Current Cancer Drug Targets Treatment of Psoriasis: A Comprehensive Review of Entire Therapies
Current Drug Safety The Bioartificial Kidney in the Treatment of Acute Kidney Injury
Current Drug Targets Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease: From a Clinical to a Molecular Association
Current Pharmaceutical Design Structural Chromosome Abnormalities Associated with Obesity: Report of Four New Subjects and Review of Literature
Current Genomics Meet Our Co-Editor
Current Enzyme Inhibition Reactions, Anti-Alzheimer and Anti COX-2 Activities of 6-Pyridin-3-yl-1Hpyrazolo[ 3,4-b]pyridin-3-amines
Current Organic Chemistry The Outbreak of Coronavirus Disease 2019 (COVID-19) and its Manifestation
Coronaviruses The Effect of Glucose-Insulin-Potassium (GIK) Infusion on Cardiovascular Function and Inflammation: Results from a Phase 1 Pilot Interventional Trial
Applied Clinical Research, Clinical Trials and Regulatory Affairs The Role of Platelets in Cardiovascular Disease: Molecular Mechanisms
Current Pharmaceutical Design Gene Therapy for Heart Transplantation-Associated Acute Rejection, Ischemia / Reperfusion Injury and Coronary Arteriosclerosis
Current Gene Therapy Editorial [Hot Topic: The Evolution of Cell Therapy Towards Enhancing Vascular Regeneration in the Clinic (Guest Editors: Drew Kuraitis and Erik J. Suuronen)]
Current Vascular Pharmacology Relationship of High-Sensitivity C-Reactive Protein Concentrations and Systolic Heart Failure
Current Vascular Pharmacology PEGylation: An Overview and Recent Advances Reported in the Patent Literature
Recent Patents on Chemical Engineering Rooteomics: The Challenge of Discovering Plant Defense-Related Proteins in Roots
Current Protein & Peptide Science HspB5/αB-Crystallin: Properties and Current Progress in Neuropathy
Current Neurovascular Research Momordica balsamina: A Medicinal and Neutraceutical Plant for Health Care Management
Current Pharmaceutical Biotechnology Targeted Radiosensitization in Prostate Cancer
Current Pharmaceutical Design